jazz pharma
Jazz and PharmaMar’s Zepzelca combo misses main goal in small cell lung cancer sub-population
December 3, 2020Research and Development PharmaMar, jazz pharma, trial failure
Jazz Pharma and PharmaMar have revealed that their jointly-developed therapy Zepzelca (lurbinectedin), when combined with doxorubicin, fell short of its …
FDA approval for Jazz and PharmaMar’s Zepzelca in metastatic small cell lung cancer
June 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing Cancer, FDA, PharmaMar, Zepzelca, jazz pharma, lung cancer
The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …
Jazz Pharma sleep disorder drug secures CHMP backing for treatment of excessive daytime sleepiness in Europe
November 18, 2019Research and Development, Sales and Marketing EMA, jazz pharma, narcolepsy, pharma, solriamfetol
Jazz Pharma’s solriamfetol has secured a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
Jazz Pharma chooses Ireland for first facility
February 17, 2014Manufacturing and Production API, Ireland, azur, jazz pharma
Jazz Pharmaceuticals will build its first in-house manufacturing facility in Ireland after years of relying on outsourcing to meet its …
Latest content
Long-acting therapies set to reshape HIV treatment market
August 21, 2026
MHRA approves Romvimza for tenosynovial giant cell tumour
August 20, 2026
